Bad news.
@BioRadLifeSci tells its customers that it will discontinue production of its rk39 rapid test for visceral #leishmaniasis next year.
The company invokes costly investments required by EU regulators. 🤔
#NTDs 1/4
This is just another example of the long list of tools for neglected diseases abandoned by companies.
As #NTDs are not lucrative, companies are tempted to stop production when additional costs to upgrade production are needed. 4/4
Join us on Tuesday 18 May, 14:00 CET, as we explore how #COVID19 has transformed #testing, implications for #diagnostics in health emergencies and universal health coverage, and how this has informed the FIND 2021 strategy.
Register➡️https://t.co/KiQMg6L9nA
@NTDFreeIndia@TheSwaddle@GHS@WHOSEARO@BMGFIndia@PCI_India_@PATHtweets Preventing #NTDs, ensuring prompt access to diagnosis and treatment of NTDs, and improving care of those suffering from the psychological consequences of these diseases should be part of a holistic approach
https://t.co/4ebkZ09uXZ
Read our working paper on #zerocovid from 2020, which suggests that even setting a goal for elimination can be advantageous from a planning perspective https://t.co/CNK71fDuDc Drawing lessons from #beatNTDs
📣Last day to register! Webinar on the #diagnostics landscape for self-testing: #HIV, viral #hepatitis & STIs, organized by @EATGx.
📅 15 April
⏰ 1 PM CET
🎙️ Sonjelle Shilton, FIND's Deputy Head HCV Access; @Emm_Fajardo@WHO; Nicole Seguy @WHO_Europe
🔗https://t.co/HijPCMH1K1
Super to see #SocSciAMR research being presented at the Association of Social Anthropologists conference #ASAResponsibility with @cmyuill @dr_loreleijones. @JustinD_902 presents trajectories of global health architecture through rational drug use @FeverStudies 👏
'Everything in the #COVID19 pandemic is about trust. Innovation is needed in behavioural science on how we as communities & individuals:
-understand epidemics & behave during them
-process information & advice
-build trust
That's as scientific as building vaccines'-@DrMikeRyan
"The latest diagnostic technologies would be required to detect early spillover in real time" - this paper published in @BMJ_latest explores the need for a global viral surveillance system to prevent the next #pandemic: https://t.co/9R05JcW5Nd
How to integrate #diagnostics into existing mechanisms for vaccine development and deployment in #response to disease #outbreaks? Don't miss this lecture by Dr. Jilian Sacks from @FINDdx on the last day of the ACDx special edition on #COVID19
Learn more ➡️https://t.co/sDJqfPOPz9
Katie Gass at #ISNTDd3 : Diagnostic needs for (MDA-amendable) NTDs are "unique". Rather than perfect tests, we need to adapt the levers that impact test performance @katiegass@TFGH@ISNTD_Press
First up in session 4 at today's @ISNTD_Press#isntdd3 is @katiegass@TFGH with 'Rethinking #NTDs#Diagnostics to achieve elimination'
✔️Specificity is key
✔️Consider the M&E tools
✔️🏃🏿♀️from single-test paradigm
✔️Adapt to reflect test performance
#BeatNTDs